These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 19085181)

  • 1. Hypnic headache associated with medication overuse: case report.
    Baykan B; Ertaş M
    Agri; 2008 Jul; 20(3):40-3. PubMed ID: 19085181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period.
    Meskunas CA; Tepper SJ; Rapoport AM; Sheftell FD; Bigal ME
    Headache; 2006 May; 46(5):766-72. PubMed ID: 16643579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid artery dissection in ergotamine abuse.
    Akova-Oztürk E; Husstedt IW; Ringelstein EB; Evers S
    Headache; 2004 Oct; 44(9):930-2. PubMed ID: 15447707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New aspects of headache treatment].
    Pichler E
    Monatsschr Ohrenheilkd Laryngorhinol; 1966 Dec; 100(12):544-50. PubMed ID: 16114452
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline.
    Valguarnera F; Tanganelli P
    Neurol Sci; 2010 Jun; 31 Suppl 1():S175-7. PubMed ID: 20464616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication overuse headache.
    Ward TN
    Prim Care; 2004 Jun; 31(2):369-80, vii. PubMed ID: 15172512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypnic headache responsive to indomethacin: second Italian case.
    Buzzi MG; Cologno D; Formisano R; Caltagirone C
    Funct Neurol; 2005; 20(2):85-7. PubMed ID: 15966272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Self-medication of regular headache: a community pharmacy-based survey in Belgium].
    Mehuys E; Paemeleire K; Van Hees T; Christiaens T; Van Bortel L; Van Tongelen I; Philippe G; Prévôt ML; Evrard B; Piette M; De Bolle L; Remon JP; Boussery K
    J Pharm Belg; 2012 Jun; (2):4-10. PubMed ID: 22978009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [After the numerous ergotamine preparations are on the way out. Migraine patients to change over to triptans].
    MMW Fortschr Med; 2003 Oct; 145(42):63. PubMed ID: 14655450
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache.
    Trucco M; Meineri P; Ruiz L;
    J Headache Pain; 2005 Sep; 6(4):334-7. PubMed ID: 16362704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypnic headache: actigraphic and polysomnographic study of a case.
    Capuano A; Vollono C; Rubino M; Mei D; Calì C; De Angelis A; Di Trapani G; Servidei S; Della Marca G
    Cephalalgia; 2005 Jun; 25(6):466-9. PubMed ID: 15910573
    [No Abstract]   [Full Text] [Related]  

  • 12. [Retroperitoneal fibrosis associated with chronic use of ergotamine: report of one case].
    Vega J; Goecke H; Santamarina M
    Rev Med Chil; 2011 Apr; 139(4):489-94. PubMed ID: 21879189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Images in clinical medicine. Four artificial heart valves.
    Bijl M; van den Brink RB
    N Engl J Med; 2005 Aug; 353(7):712. PubMed ID: 16107624
    [No Abstract]   [Full Text] [Related]  

  • 14. [Daily chronic headache in patients with migraine induced by abuse of ergotamine-analgesics: response due to a protocol of outpatient treatment].
    Pascual J; Berciano J
    Neurologia; 1993; 8(7):212-5. PubMed ID: 8104438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Severity of Dependence Scale detects people with medication overuse: the Akershus study of chronic headache.
    Grande RB; Aaseth K; Saltyte Benth J; Gulbrandsen P; Russell MB; Lundqvist C
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):784-9. PubMed ID: 19279030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Lipton RB
    Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo response in a patient with chronic migraine and ergotic overuse.
    Pascual-Lozano AM; Chamarro-Lazáro R; Láinez MJ
    Cephalalgia; 2005 May; 25(5):391-4. PubMed ID: 15839854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up.
    Zidverc-Trajkovic J; Pekmezovic T; Jovanovic Z; Pavlovic A; Mijajlovic M; Radojicic A; Sternic N
    Cephalalgia; 2007 Nov; 27(11):1219-25. PubMed ID: 17888081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Headache induced by chronic substance use: analysis of medication overused and minimum dose required to induce headache.
    Relja G; Granato A; Maria Antonello R; Zorzon M
    Headache; 2004 Feb; 44(2):148-53. PubMed ID: 14756853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: current perspectives.
    Young WB
    Headache; 1997; 37 Suppl 1():S42-5. PubMed ID: 9009473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.